Latest news with #AISHealthcare
Business Wire
5 days ago
- Business
- Business Wire
AIS Healthcare Awarded a Group Purchasing Agreement for 503A Intrathecal Compounded Medications with Premier, Inc.
DALLAS--(BUSINESS WIRE)--AIS Healthcare has been awarded a group purchasing agreement for 503A intrathecal compounded medications with Premier, Inc., effective July 1, 2025. The new agreement allows Premier members, at their discretion, to take advantage of special pricing and terms pre-negotiated by Premier for sterile, patient-specific intrathecal pain pump medications. In addition, to assist with compliance policies, this agreement with Premier will provide member hospitals with site audit evaluations as well as ongoing quality reporting. 'Partnering with Premier allows us to bring our high‑quality, patient‑specific medications and services to more patients and providers across the country. By combining Premier's expansive network with our expertise in delivering safe, reliable, and longer‑dated compounded medications, we can help meet the growing 503A outsourcing needs for Premier's member organizations with confidence and consistency. Together, we are delivering the best possible care to patients,' said Simon Castellanos, CEO of AIS Healthcare. Premier, Inc. is a leading healthcare improvement company, bringing more than 4,400 US hospitals and health systems and approximately 250,000 other providers and organizations together to transform health care. With integrated data and analytics, collaboratives, supply chain solutions, and consulting and other services, Premier enables better care and outcomes at a lower cost. About AIS Healthcare AIS Healthcare is a 503A pharmacy that compounds intrathecal medications for Targeted Drug Delivery (TDD). As the leading provider of TDD, AIS Healthcare is committed to providing industry leading intrathecal medications and the highest quality care. At the center of our TDD operation are our 2 state-of-the-art 503A specialty compounding pharmacies, which prepare and ship more than 145,000 patient-specific prescriptions annually. At both facilities, we go beyond industry and state standards to produce medications of the highest quality. We use a proven, proprietary process that combines aseptic processing with terminal sterilization on patient-specific prescriptions to achieve higher sterility assurance and extended Beyond-Use Dates (BUD). To learn more about AIS Healthcare, please contact Chad Jeske at cjeske@ or visit our website at
Business Wire
10-07-2025
- Business
- Business Wire
AIS Healthcare Recognized with URAC Leader in Performance Measurement Award
DALLAS--(BUSINESS WIRE)--AIS Healthcare, the leading provider of targeted drug delivery (TDD) and infusion care solutions, is proud to announce that it has been named a 2024 Pioneer in URAC's Leaders in Performance Measurement (LPM) recognition program. This is the second year in a row that AIS Healthcare has been recognized as a Pioneer by URAC for promoting trust in the quality of care delivered through performance measurement activities. To be recognized with the Pioneer in Performance Measurement Award, an organization is required to make key contributions to advance performance measurements and participate in activities that go beyond the mandatory reporting requirements, such as submission of exploratory measures, all with the purpose of helping improve the health and well-being of the populations being served. URAC is one of the nation's leading independent health care accreditation organizations, with certification programs that set the highest standards in quality and safety. 'We are honored to have been named a 2024 Pioneer by URAC,' said Simon Castellanos, AIS Healthcare CEO. 'This recognition, for the second year in a row, is a testament to the dedication of our entire company to put patient safety first. I could not be prouder of this team and their unwavering commitment to ensuring quality, sterility, and excellence across all our pharmacy operations. As the leading provider of targeted drug delivery and infusion care solutions, AIS Healthcare is committed to doing more of what matters. This accomplishment underscores the company's commitment to going beyond what's expected to advance quality care and improve the lives of patients. AIS Healthcare is also dually accredited by URAC and the Accreditation Commission for Health Care (ACHC), further setting it apart from other compounding pharmacies and infusion services providers. Learn more at About AIS Healthcare Advancing quality. Improving lives. As the leading provider of targeted drug delivery and infusion care solutions, AIS Healthcare is committed to doing more of what matters. From pharmacies that put patient safety first to comprehensive services that enhance the entire care experience, we go beyond the expected in everything we do. Learn more at About URAC Founded in 1990, URAC is the independent leader in promoting healthcare quality through leadership, accreditation, measurement and innovation. URAC is a nonprofit organization using evidence-based measures and developing standards through inclusive engagement with a range of stakeholders committed to improving the quality of healthcare. Our portfolio of accreditation and certification programs span the healthcare industry, addressing healthcare management, healthcare operations, health plans, pharmacies, telehealth providers, physician practices and more. URAC accreditation is a symbol of excellence for organizations to showcase their validated commitment to quality and accountability.
